12:00 AM
Jun 13, 2011
 |  BC Week In Review  |  Company News  |  Other News

Airway Therapeutics, Cincinnati Children's Hospital Medical Center pulmonary news

Cincinnati Children's Hospital granted newco Airway Therapeutics an exclusive, worldwide license to commercialize pulmonary therapy research conducted at the hospital, including preclinical recombinant human surfactant protein D (rhSP-D). Airway will initially focus on...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >